Fidelity Investments
XGN icon

Fidelity Investments’s Exagen XGN Stock Holding History

Fidelity Investments’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-357
Closed -$2.49K – 5599
2025
Q2 		$2.49K Buy
+357
New +$2.17K ﹤0.01% 4832
2022
Q3 		– Sell
-165
Closed -$1K – 5466
2022
Q2 		$1K Buy
165
+39
+31% +$227 ﹤0.01% 4819
2022
Q1 		$1K Buy
+126
New +$1.09K ﹤0.01% 4861

Other funds holding XGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Fidelity Investments's XGN Position: Q3 2025 in Review

Fidelity Investments sold out of Exagen (XGN) in Q3 2025, closing a stake of 357 shares — an estimated $2.49K sold.

Fidelity Investments first reported a position in XGN in Q1 2022 and held it in 3 quarters. The position peaked at $2.49K in Q2 2025. 62 funds tracked by Wall St. Rank hold XGN as of Q3 2025.

  • Fidelity Investments reported no remaining Exagen position as of Q3 2025 after selling out during the quarter.
  • Fidelity Investments sold 357 Exagen shares in Q3 2025, an estimated $2.49K.
  • Fidelity Investments first reported a position in Exagen in Q1 2022 and held it in 3 quarters.
  • Fidelity Investments's Exagen position peaked at $2.49K in Q2 2025.
  • 62 funds tracked by Wall St. Rank held Exagen as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.